Journals / Pamukkale Tıp Dergisi / 2023 / Cilt: 16 - Sayı: 2

Investigation of the possible relation of apelin, kynurenine and IL-4/IL-10/IL-12/ Tnf-α levels with clinical and metabolic parameters in obesity

Obezitede apelin, kinürenin ve IL-4/IL-10/IL-12/Tnf-α düzeylerinin klinik ve metabolik parametrelerle olası ilişkisinin araştırılması

Pages
282–289
Publication Date
2023-04-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results demonstrate that kynurenine, IL-4, and IL-12 have a complex role in obesity and can be used as therapeutic targets.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Obesity is a medical condition caused by excess body fat that accumulates at a level that can have a detrimental impact on health.
📊
Key Findings & Data:In our study, we purposed to specify the apelin, kynurenine, IL-4, IL-10, IL-12, TNF-α protein levels in obese individuals and healthy control groups, and to research the possible relationship between clinical parameters with the data to be obtained.
💡
Conclusion & Impact:The results demonstrate that kynurenine, IL-4, and IL-12 have a complex role in obesity and can be used as therapeutic targets.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Obezite · kronik inflamasyon apelin · kinurenin

Abstract

Purpose: Obesity is a medical condition caused by excess body fat that accumulates at a level that can have a detrimental impact on health. Altered glucose and lipid metabolism, low-grade chronic inflammation controbutes to the pathogenesis of obesity and obesity-related metabolic dysfunction. In our study, we purposed to specify the apelin, kynurenine, IL-4, IL-10, IL-12, TNF-α protein levels in obese individuals and healthy control groups, and to research the possible relationship between clinical parameters with the data to be obtained. Materials and methods: The levels of apelin, kynurenine, IL-4, IL-10, IL-12, TNF-α in serum/plasma samples were determined with enzyme-linked immunosorbent assay. Absorbance of the samples were measured on a microplate reader spectrophotometrically at a wavelength of 450 nm.Results: The levels of kynurenine, IL-4, and IL-12 in the serum were higher in control group than in obese patients (p=0.009, p=0.004, p=0.002, respectively). The levels of TNF- α, IL-10, and apelin did not differ substantially between the obese patients and the control group (p=0.277, p=0.711, p=0.472, respectively).Conclusion: Inflammation and altered immune response are two important components of obesity. They play a significant part in the emergence of obesity-related metabolic disorders. Alterations in adipokine levels may lead to the occurence and maintenance of insulin resistance and systemic inflammation in obesity. The results demonstrate that kynurenine, IL-4, and IL-12 have a complex role in obesity and can be used as therapeutic targets.

Özet

Amaç: Obezite, sağlığı olumsuz etkileyebilecek düzeyde biriken aşırı vücut yağının neden olduğu tıbbi bir durumdur. Değişen glikoz ve lipid metabolizması, düşük dereceli kronik inflamasyon, obezite ve obezite ile ilişkili metabolik disfonksiyonun patogenezinde rol oynar. Çalışmamızda obez hastalarda ve sağlıklı kontrol gruplarında apelin, kinurenin, IL-4, IL-10, IL-12, TNF-α serum protein düzeylerini belirlemeyi ve klinik parametreler ile arasındaki olası ilişkiyi araştırmayı amaçladık.Gereç ve yöntem: Serum/plazma örneklerindeki apelin, kinurenin, IL-4, IL-10, IL-12, TNF-α seviyeleri, enzim bağlantılı immunosorbent testi ile ölçüldü. Numunelerin absorbansı, 450 nm dalga boyunda spektrofotometrik olarak bir mikroplaka okuyucu ile belirlendi.Bulgular: Kontrol grubunun serumlarındaki Kinurenin, IL-4 ve IL-12 düzeylerinin obez hastalara oranla anlamlı düzeyde daha yüksek olduğu belirlenmiştir (sırasıyla p=0.009, p=0,004, p=0,002). TNF-α, IL-10 ve apelin düzeyleri değerlendirildiğinde ise obez hastalar ve kontrol grubu arasında anlamlı bir fark olmadığı tespit edilmiştir (sırasıyla p=0,277, p=0,711, p=0,472).Sonuç: Enflamasyon ve değişmiş bağışıklık yanıtı obezitenin iki önemli bileşenidir. Bu bileşenler obeziteye bağlı metabolik hastalıkların oluşumunda önemli rol oynamaktadırlar. Adipokin düzeylerindeki değişiklikler, obezitede sistemik inflamasyonun gelişimine ve insülin direncinin sürdülmesine yol açabilir. Elde edilen sonuçlar, kinurenin, IL-4 ve IL-12'nin obezitede karmaşık bir role sahip olduğunu ve terapötik hedefler olarak kullanılabileceğini göstermektedir.

🔖

Cite This Article

MOĞUL, İ. C. B., DODURGA, Y., UYGUR, E. P., YAYLALI, G. F., AKDAĞ, Z. (2023). Investigation of the possible relation of apelin, kynurenine and IL-4/IL-10/IL-12/ Tnf-α levels with clinical and metabolic parameters in obesity. Pamukkale Tıp Dergisi, Cilt: 16 - Sayı: 2, 282–289. https://ajindex.com/articles/888220

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Obesity and overweight. WHO Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed March 04, 2020 2. Wolowczuk I, Hennart B, Leloire A, et al. Tryptophan metabolism activation by indoleamine 2,3- dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. Am J Physiol Regulatory Integr Comp Physiol 2012
  2. https://doi.org/10.1152/ajpregu.00373.2011 3. Liu J, Liu M, Chen L. Novel pathogenesis: regulation of apoptosis by Apelin/APJ system. Acta Biochim Biophys Sin 2017
  3. https://doi.org/10.1093/abbs/gmx035 4. Castan Laurell I, Dray C, Valet P. The therapeutic potentials of apelin in obesity-associated diseases. Mol Cell Endocrinol 2021
  4. 111278. https://doi.org/10.1016/j.mce.2021.111278 5. Palmer ES, Irwin N, O’Harte FPM. Potential therapeutic role for apelin and related peptides in diabetes: an update. Clin Med Insights Endocrinol Diabetes 2022
  5. 11795514221074680. https://doi.org/10.1177/11795514221074679 6. Soriguer F, Garrido Sanchez L, et al. Apelin levels are ıncreased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg 2009
  6. https://doi.org/10.1007/s11695-009-9955-y 7. Skarsvik S, Ludvigsson J, Vaarala O. Aberrant regulation of interleukin-12 receptor 2 chain on type 1 cytokine stimulated T lymphocytes in type 1 diabetes. Immunology 2005
  7. https://doi.org/10.1111/j.1365-2567.2004.02102.x 8. Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, Borkenstein M. Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. Exp Clin Endocrinol Diabetes 2004
  8. https://doi.org/10.1055/s-2004-821023 9. Solon Biet SM, Cogger VC, Pulpitel T, et al. Branched chain amino acids impact health and lifespan indirectly via amino acid balance and appetite control. Nat Metab 2019
  9. https://doi.org/10.1038/s42255-019-0059-2 10. Mangge H, Summers K L, Meinitzer A, et al. Obesity-related dysregulation of the tryptophan kynurenine metabolism: role of age and parameters of the metabolic syndrome. Obesity 2014
  10. https://doi.org/10.1002/oby.20491 11. Cussotto S, Delgado I, Anesi A, et al. Tryptophan metabolic pathways are altered in obesity and are associated with systemic inflammation. Front Immunol 2020
  11. https://doi.org/10.3389/fimmu.2020.00557 12. Polyzos KA, Ovchinnikova O, Berg M. et al. Inhibition of indoleamine 2,3-dioxygenase pro